Jens Luehring serves as Executive at Bellerophon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jens Luehring has executed 6 insider transactions totaling $4.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 21, 2018 involved receiving (via award) 14,555 shares valued at $0.
Jens Luehring currently holds 95,213 shares of Bellerophon Therapeutics, Inc. (BLPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jens Luehring has been a net buyer of BLPH stock. They have purchased $4.3M and sold $0 worth of shares.
Jens Luehring's most recent insider trade was on Jun 21, 2018, when they sold 14,555 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 28, 2017 | BLPH | $0 | Award | 30,798 | $N/A | Discretionary |
| Dec 9, 2016 | BLPH | $11.2K | Purchase | 20,000 | $0.56 | Discretionary |
| Apr 28, 2016 | BLPH | $0 | Award | 19,860 | $N/A | Discretionary |
| Feb 19, 2015 | BLPH | $4.3M | Purchase | 358,916 | $12.00 | Discretionary |